Intravascular catheter migration: A cross-sectional and health-economic comparison of adhesive and subcutaneous engineered stabilisation devices for intravascular device securement.


Journal

The journal of vascular access
ISSN: 1724-6032
Titre abrégé: J Vasc Access
Pays: United States
ID NLM: 100940729

Informations de publication

Date de publication:
Jan 2020
Historique:
pubmed: 5 6 2019
medline: 23 2 2020
entrez: 5 6 2019
Statut: ppublish

Résumé

The Infusional Services Team at a large cancer centre in Belfast, Northern Ireland, performed a cross-sectional analysis of two catheter securement technologies to address an area of frequent, but underestimated concern - peripherally inserted central catheter migration and dislodgement. Healthcare practitioner and patient feedback, along with economic impact, were assessed. The costs associated with catheter replacement during the adhesive device group study period were calculated using an average cost per insertion, based on material costs required for the procedure. Other factors were the replacement cost of the adhesive engineered securement device with each dressing change. In the subcutaneous securement group, the material costs were adjusted for use of the subcutaneous device as it remained in situ for the duration of the catheters' dwell time. This review found that subcutaneous securement offers both patient and facilities a safe, effective and economical alternative for device securement with patients who are unable to tolerate or have successful securement with adhesive securement devices. The use of subcutaneous devices provided for reduced risks for peripherally inserted central catheters in terms of dislodgement, migration or malposition, alleviating the potential risks to develop catheter-related thrombosis and device-related infection.

Identifiants

pubmed: 31159638
doi: 10.1177/1129729819851059
doi:

Substances chimiques

Tissue Adhesives 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33-38

Auteurs

Dympna McParlan (D)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

L Edgar (L)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

M Gault (M)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

S Gillespie (S)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

R Menelly (R)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

M Reid (M)

Infusional Services Team, Cancer Centre, Belfast City Hospital, Belfast, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH